Literature DB >> 29074210

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response.

Lucien Marchand1, Valérie Paulus2, Nicole Fabien3, Maurice Pérol2, Charles Thivolet4, Julien Vouillarmet4, Pierre Saintigny2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29074210     DOI： 10.1016/j.jtho.2017.07.021

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  12 in total

1.  Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis.

Authors:  Melissa Sum; Franco Vallejo Garcia
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 2.  Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Authors:  Angelos Kyriacou; Eka Melson; Wentin Chen; Punith Kempegowda
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

Review 3.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 4.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

5.  New-onset insulin-dependent diabetes due to nivolumab.

Authors:  Ali A Zaied; Halis K Akturk; Richard W Joseph; Augustine S Lee
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-03-28

6.  Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome.

Authors:  Giulia Lanzolla; Alberto Coppelli; Mirco Cosottini; Stefano Del Prato; Claudio Marcocci; Isabella Lupi
Journal:  J Endocr Soc       Date:  2019-01-08

7.  Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.

Authors:  Jeroen M K de Filette; Joeri J Pen; Lore Decoster; Thomas Vissers; Bert Bravenboer; Bart J Van der Auwera; Frans K Gorus; Bart O Roep; Sandrine Aspeslagh; Bart Neyns; Brigitte Velkeniers; Aan V Kharagjitsingh
Journal:  Eur J Endocrinol       Date:  2019-09       Impact factor: 6.664

8.  A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review.

Authors:  Tomoo Kakimoto; Mamoru Sasaki; Tatsuya Yamamoto; Arifumi Iwamaru; Kentaro Ogata; Ko Lee; Shingo Nakayama; Naoto Minematsu
Journal:  Case Rep Oncol Med       Date:  2019-10-15

9.  Pulmonary Pleomorphic Carcinoma Mimicking Primary Sarcoma of the Neck: A Case Report and Literature Review.

Authors:  Daishi Ogawa; Masahisa Arahata; Masato Kuriyama; Shunji Shinagawa; Gakuto Tomizawa; Yukihiro Shimizu
Journal:  Clin Interv Aging       Date:  2021-02-23       Impact factor: 4.458

10.  Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report.

Authors:  Shoko Marshall; Aki Kizuki; Tadashi Kitaoji; Hiroshi Imada; Hayato Kato; Mana Hosoda; Motonao Ishikawa; Hiroshi Sakura
Journal:  Case Rep Oncol       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.